- Tytuł:
- Phase 1 trial of navitoclax and sorafenib in patients with relapsed or refractory solid tumors with hepatocellular carcinoma expansion cohort
- Autorzy:
- Źródło:
- Investigational New Drugs: Novel Anti-Cancer Therapeutics and Therapies. 42(1):127-135
Czasopismo naukowe